Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linong Ji

Showing results (11-20 of 587) with videos related to

Pageof 59
Sort By:
Chinese Medical Journal|March 4, 2022
Estimation of atherosclerotic cardiovascular disease risk in type 2 diabetesXiaoling Cai, Chu Lin, Linong Ji
Diabetes, Obesity & Metabolism|November 2, 2021
Cardiovascular benefits beyond urinary glucose excretion: A hypothesis generated from two meta-analysesChu Lin, Xiaoling Cai, Linong Ji
Calcified Tissue International|June 29, 2022
An Update on Animal Models of Osteogenesis ImperfectaFang Lv, Xiaoling Cai, Linong Ji
Zhonghua Yi Xue Za Zhi|January 3, 2003
[The role of urotensin II gene in the genetic susceptibility to type 2 diabetes in Chinese population]Fang Zhu, Linong Ji, Bin Luo
Bone|April 7, 2020
Response to "Denosumab and Romosozumab do not increase the risk of cardiovascular events in patients with primary osteoporosis: A reanalysis of the meta-analysis"Fang Lv, Xiaoling Cai, Linong Ji
The Journal of Clinical Endocrinology and Metabolism|August 30, 2024
Low C-Reactive Protein Alleles in Hepatocyte Nuclear Factor 1A Are Associated With an Increased Risk of Cardiovascular DiseaseChaochao Yang, Linong Ji, Xueyao Han
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|April 14, 2026
[False positives in female testosterone testing and the diagnostic value of mass spectrometry]Man Wu, Yingying Luo, Linong Ji
Diabetes Research and Clinical Practice|November 24, 2023
Association between frequency of self-monitoring of blood glucose and glycemic control in patients with type 2 diabetesXiaoyan Sun, Xianghai Zhou, Shaobo Li, et al.
Diabetes/Metabolism Research and Reviews|September 30, 2015
DPP-4 inhibitors and risk of infections: a meta-analysis of randomized controlled trialsWenjia Yang, Xiaoling Cai, Xueyao Han, et al.
Expert Opinion on Pharmacotherapy|November 2, 2017
Comparison between insulin degludec/liraglutide treatment and insulin glargine/lixisenatide treatment in type 2 diabetes: a systematic review and meta-analysisXiaoling Cai, Xueying Gao, Wenjia Yang, et al.
Pageof 59

Showing results (11-20 of 587) with videos related to

Sort By:
Pageof 59
Chinese Medical Journal|March 4, 2022
Estimation of atherosclerotic cardiovascular disease risk in type 2 diabetesXiaoling Cai, Chu Lin, Linong Ji
Diabetes, Obesity & Metabolism|November 2, 2021
Cardiovascular benefits beyond urinary glucose excretion: A hypothesis generated from two meta-analysesChu Lin, Xiaoling Cai, Linong Ji
Calcified Tissue International|June 29, 2022
An Update on Animal Models of Osteogenesis ImperfectaFang Lv, Xiaoling Cai, Linong Ji
Zhonghua Yi Xue Za Zhi|January 3, 2003
[The role of urotensin II gene in the genetic susceptibility to type 2 diabetes in Chinese population]Fang Zhu, Linong Ji, Bin Luo
Bone|April 7, 2020
Response to "Denosumab and Romosozumab do not increase the risk of cardiovascular events in patients with primary osteoporosis: A reanalysis of the meta-analysis"Fang Lv, Xiaoling Cai, Linong Ji
The Journal of Clinical Endocrinology and Metabolism|August 30, 2024
Low C-Reactive Protein Alleles in Hepatocyte Nuclear Factor 1A Are Associated With an Increased Risk of Cardiovascular DiseaseChaochao Yang, Linong Ji, Xueyao Han
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|April 14, 2026
[False positives in female testosterone testing and the diagnostic value of mass spectrometry]Man Wu, Yingying Luo, Linong Ji
Diabetes Research and Clinical Practice|November 24, 2023
Association between frequency of self-monitoring of blood glucose and glycemic control in patients with type 2 diabetesXiaoyan Sun, Xianghai Zhou, Shaobo Li, et al.
Diabetes/Metabolism Research and Reviews|September 30, 2015
DPP-4 inhibitors and risk of infections: a meta-analysis of randomized controlled trialsWenjia Yang, Xiaoling Cai, Xueyao Han, et al.
Expert Opinion on Pharmacotherapy|November 2, 2017
Comparison between insulin degludec/liraglutide treatment and insulin glargine/lixisenatide treatment in type 2 diabetes: a systematic review and meta-analysisXiaoling Cai, Xueying Gao, Wenjia Yang, et al.
Pageof 59